Hemab Therapeutics (COAG) IPO deck
Hemab Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for blood coagulation disorders, including rare bleeding and thrombotic conditions.
Hemab Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for blood coagulation disorders, including rare bleeding and thrombotic conditions.
%20IPO%20deck){kind=link}